Monica Stonehill

SAN DIEGO — Patients with diabetes who were prescribed glucagon-like peptide-1 receptor agonists had lower odds of metabolic dysfunction-associated steatotic liver disease after liver transplantation, noted a presenter at The Liver Meeting. “GLP-1RAs are quickly becoming the cornerstone of diabetes and weight loss management,” Mohammad S. Siddiqui, MD, from the Virginia

Black and Native Hawaiian or other Pacific Islander patients with early-onset colorectal cancer had higher risk for mortality compared with white patients, with data supporting the role of social determinants of health in those differences. “Although published data has pointed to the rise in incidence of early-onset CRC among several racial and ethnic groups, our results indicate that there

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the mounting threat of cyberattacks on health care organizations and how employees are often “the weakest link” in their defense. In this month’s Healio Exclusive, Healio reported on the aftermath of the Feb. 21st ransomware attack on Change Healthcare that required it to pay $22 million in ransom to regain control

Glucagon-like peptide-1 receptor agonist use for obesity management continues to rise, but not without concerns for use during elective surgery – uncertainty remains over whether halting them beforehand is the safest option for patients.In June 2023, the American Society of Anesthesiologists recommended holding GLP-1s at least 1 week prior to any elective surgery that required sedation due

Newly available noninvasive colorectal cancer tests have opened the doors to an uptick in screening, especially the first FDA-approved blood test. However, experts are unsure whether these will be as effective as colonoscopy.In July, the FDA approved Guardant Health’s Shield, the first blood test approved as a primary CRC screening option. It joins the pipeline of noninvasive screening

Hispanic patients hospitalized for alcohol use disorder were more likely to develop alcohol-associated hepatitis, decompensated cirrhosis and related complications compared with non-Hispanic white patients, according to published data. “Alcohol use disorder (AUD), a major contributor to alcohol-associated liver disease (ALD), has been increasing in the United States,” Soo Young Hwang,

There are approximately 100,000 alcohol-related cancer cases annually in the U.S. and 20,000 deaths due to alcohol-related cancer, according to an HHS press release.This is one of the many tipping points that sparked U.S. Surgeon General Vivek Murthy, MD, MBA, to issue an advisory designed to raise awareness about alcohol consumption and reduce the incidence of alcohol-related cancers and deaths.

A 2016 report from the Health Resources and Services Administration National Center for Health Workforce Analysis projected a shortage of 1,630 full-time physicians by 2025 in the field of gastroenterology.However, that is not where the shortage ends. According to Karmen Blackwell, a Health Resources and Services Administration (HRSA) spokesperson, “In 2037, there will be a projected

Physiological metrics captured via wearable devices may help identify and predict flares in inflammatory bowel disease, Robert P. Hirten, MD, told Healio, and could potentially play a role in remote monitoring of disease activity. “As gastroenterologists, one of the things that we find is that between office visits, there sometimes can be relatively little contact or interaction between

Currently, more than 300 million people are diagnosed with hepatitis around the world, according to the World Hepatitis Alliance. Cases continue to rise, with more than 2 million new cases each year. Among the five hepatitis viruses, HBV, HCV and HDV usually cause chronic disease, liver cancer and cirrhosis, whereas HAV and HEV cause acute disease but may lead to more serious complications in